Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126445891 | 12644589 | 1 | I | 20140505 | 20160803 | 20160811 | 20160811 | EXP | US-ASTRAZENECA-2016SE85287 | ASTRAZENECA | 25375.00 | DY | F | Y | 83.90000 | KG | 20160811 | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126445891 | 12644589 | 1 | PS | SYMBICORT | BUDESONIDEFORMOTEROL FUMARATE DIHYDRATE | 1 | Respiratory (inhalation) | 160/4.5 UG, ONE PUFF DAILY | 21929 | ||||||||||
126445891 | 12644589 | 2 | SS | PULMICORT FLEXHALER | BUDESONIDE | 1 | Respiratory (inhalation) | 180 UG, 1 PUFF DAILY | U | U | PAEC | 0 | INHALATION POWDER | ||||||
126445891 | 12644589 | 3 | SS | PULMICORT FLEXHALER | BUDESONIDE | 1 | Respiratory (inhalation) | 180 UG, 1 PUFF DAILY | U | U | PAEC | 0 | INHALATION POWDER | ||||||
126445891 | 12644589 | 4 | SS | PULMICORT FLEXHALER | BUDESONIDE | 1 | Respiratory (inhalation) | 180 UG, 1 PUFF DAILY | U | U | 0 | INHALATION POWDER | |||||||
126445891 | 12644589 | 5 | SS | PULMICORT FLEXHALER | BUDESONIDE | 1 | Respiratory (inhalation) | 180 UG, 1 PUFF DAILY | U | U | 0 | INHALATION POWDER | |||||||
126445891 | 12644589 | 6 | C | COMBIVENT | ALBUTEROL SULFATEIPRATROPIUM BROMIDE | 1 | ONE PUFF FOUR TIMES PER DAY | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
126445891 | 12644589 | 1 | Chronic obstructive pulmonary disease |
126445891 | 12644589 | 2 | Chronic obstructive pulmonary disease |
126445891 | 12644589 | 3 | Pneumonitis |
126445891 | 12644589 | 4 | Chronic obstructive pulmonary disease |
126445891 | 12644589 | 5 | Pneumonitis |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
126445891 | 12644589 | HO |
126445891 | 12644589 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
126445891 | 12644589 | Eye pain | |
126445891 | 12644589 | Off label use | |
126445891 | 12644589 | Pneumonitis | |
126445891 | 12644589 | Product packaging issue | |
126445891 | 12644589 | Product use issue | |
126445891 | 12644589 | Squamous cell carcinoma of lung |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
126445891 | 12644589 | 1 | 2013 | 0 | ||
126445891 | 12644589 | 2 | 20160711 | 0 | ||
126445891 | 12644589 | 3 | 20160711 | 0 |